Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,502 Infectious Disease
clinical trials

Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Kapiolani Medical Center for Women and Children
mi
from
Honolulu, HI
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Nemours Children's Clinic - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
East Tennessee Children's Hospital
mi
from
Knoxville, TN
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Valley Children's Hospital
mi
from
Madera, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
West Virginia University Healthcare
mi
from
Morgantown, WV
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Evaluation of the Atlas Genetics io® CTNG System
Status: Enrolling, Phase
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Evaluation of the Atlas Genetics io® CTNG System
Status: Enrolling, Phase
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Evaluation of the Atlas Genetics io® CTNG System
Status: Enrolling, Phase
Updated: 12/31/1969
Planned Parenthood Southeastern Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clostridium Difficile Infection Recurrence Clinical Trial
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
Status: Enrolling, Phase II
Updated: 12/31/1969
Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Clostridium Difficile Infection Recurrence Clinical Trial
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
Status: Enrolling, Phase II
Updated: 12/31/1969
Investigator Site - Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clostridium Difficile Infection Recurrence Clinical Trial
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
Status: Enrolling, Phase II
Updated: 12/31/1969
Morristown
mi
from
Morristown, NJ
Click here to add this to my saved trials
Clostridium Difficile Infection Recurrence Clinical Trial
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
Status: Enrolling, Phase II
Updated: 12/31/1969
Investigator Site - San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Clostridium Difficile Infection Recurrence Clinical Trial
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
Status: Enrolling, Phase II
Updated: 12/31/1969
Investigational Site - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Clostridium Difficile Infection Recurrence Clinical Trial
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
Status: Enrolling, Phase II
Updated: 12/31/1969
San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Clostridium Difficile Infection Recurrence Clinical Trial
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington, DC
mi
from
Washington DC,
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases Clinical Trial
Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Nephrology / Urology, Neurology Clinical Trial
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Miami Medical Center
mi
from
Miami, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Nephrology / Urology, Neurology Clinical Trial
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Local Institution
mi
from
Bronx, NY
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Nephrology / Urology, Neurology Clinical Trial
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Paramount Medical Research & Consulting, Llc
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Nephrology / Urology, Neurology Clinical Trial
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Nephrology / Urology, Neurology Clinical Trial
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Nephrology / Urology, Neurology Clinical Trial
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Carolina Arthritis Associates
mi
from
Wilmington, NC
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Colorado Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Alabama Medical Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling, Phase III
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling, Phase III
Updated: 12/31/1969
Jefferson Dermatology Associates
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling, Phase III
Updated: 12/31/1969
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
HSV Infection Clinical Trial
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults
Status: Enrolling, Phase II
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
IVIg to Treat BK Viremia in Kidney Transplant Recipients
Status: Enrolling, Phase I
Updated: 4/26/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Mobile-Based Application "MyChoices"
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Invasive Fungal Infection Clinical Trial
Registry of Patients Treated With Systemic Mold-Active Triazoles
Status: Enrolling, Phase
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Invasive Fungal Infection Clinical Trial
Registry of Patients Treated With Systemic Mold-Active Triazoles
Status: Enrolling, Phase
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Invasive Fungal Infection Clinical Trial
Registry of Patients Treated With Systemic Mold-Active Triazoles
Status: Enrolling, Phase
Updated: 12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Invasive Fungal Infection Clinical Trial
Registry of Patients Treated With Systemic Mold-Active Triazoles
Status: Enrolling, Phase
Updated: 12/31/1969
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Invasive Fungal Infection Clinical Trial
Registry of Patients Treated With Systemic Mold-Active Triazoles
Status: Enrolling, Phase
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Invasive Fungal Infection Clinical Trial
Registry of Patients Treated With Systemic Mold-Active Triazoles
Status: Enrolling, Phase
Updated: 12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Invasive Fungal Infection Clinical Trial
Registry of Patients Treated With Systemic Mold-Active Triazoles
Status: Enrolling, Phase
Updated: 12/31/1969
Tulane Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Invasive Fungal Infection Clinical Trial
Registry of Patients Treated With Systemic Mold-Active Triazoles
Status: Enrolling, Phase
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Invasive Fungal Infection Clinical Trial
Registry of Patients Treated With Systemic Mold-Active Triazoles
Status: Enrolling, Phase
Updated: 12/31/1969
St. Joseph's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Invasive Fungal Infection Clinical Trial
Registry of Patients Treated With Systemic Mold-Active Triazoles
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Invasive Fungal Infection Clinical Trial
Registry of Patients Treated With Systemic Mold-Active Triazoles
Status: Enrolling, Phase
Updated: 12/31/1969
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Click here to add this to my saved trials
Cough Clinical Trial
Pilot of Zinc Acetate to Improve Chronic Cough
Status: Enrolling, Phase II
Updated: 12/31/1969
St. Vincent Health
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Immunology / Infectious Diseases, Other Clinical Trial
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Immunology / Infectious Diseases, Other Clinical Trial
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Status: Enrolling, Phase III
Updated: 12/31/1969
Maricopa Integrated Health System
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)
Status: Enrolling, Phase II
Updated: 12/31/1969
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)
Status: Enrolling, Phase II
Updated: 12/31/1969
Chattanooga's Program in Women's Oncology
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Catheter-associated Urinary Tract Infection Clinical Trial
Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery
Status: Enrolling, Phase IV
Updated: 10/2/2017
Carolinas Health Care System
mi
from
Charlotte, NC
Click here to add this to my saved trials
Wound Infection Clinical Trial
Prevena™ vs Dermabond in Groin Wound Infections in Vascular Surgery
Status: Enrolling
Updated: 12/31/1969
State University of New York at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Herpes Zoster Ophthalmicus Clinical Trial
Zoster Eye Disease Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Herpes Zoster Ophthalmicus Clinical Trial
Zoster Eye Disease Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Herpes Zoster Ophthalmicus Clinical Trial
Zoster Eye Disease Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Herpes Zoster Ophthalmicus Clinical Trial
Zoster Eye Disease Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Herpes Zoster Ophthalmicus Clinical Trial
Zoster Eye Disease Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Herpes Zoster Ophthalmicus Clinical Trial
Zoster Eye Disease Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
LSU Health Science Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Herpes Zoster Ophthalmicus Clinical Trial
Zoster Eye Disease Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
Casey Eye Institute, Oregon Health & Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Herpes Zoster Ophthalmicus Clinical Trial
Zoster Eye Disease Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
Virginia Eye Institute
mi
from
Richmond, VA
Click here to add this to my saved trials
Herpes Zoster Ophthalmicus Clinical Trial
Zoster Eye Disease Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Suspected or Documented Gram-negative Bacterial Infection Clinical Trial
A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)
Status: Enrolling, Phase I
Updated: 12/31/1969
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Suspected or Documented Gram-negative Bacterial Infection Clinical Trial
A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)
Status: Enrolling, Phase I
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Refractory Mycosis Fungoides Clinical Trial
Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides
Status: Enrolling, Phase II
Updated: 11/16/2017
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Specimen Collection and Transport Workflow Evaluations for CLIA-waived Molecular Testing
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Oncology Clinical Trial
Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Recurrent Prostate Carcinoma Clinical Trial
Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation
Status: Enrolling, Phase I
Updated: 12/31/1969
Sidney Kimmel Cancer Center - Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Fecal Microbiota Transplant National Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Fecal Microbiota Transplant National Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Ochsner
mi
from
New Orleans, LA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Fecal Microbiota Transplant National Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Carle Foundation Hospital
mi
from
Urbana, IL
Click here to add this to my saved trials
Respiratory Syncytial Virus Infections Clinical Trial
A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Jacobi Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Helicobacter Infections Clinical Trial
Specimen Collection Study for H. Pylori Testing
Status: Enrolling, Phase
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Lower Respiratory Tract Infection Clinical Trial
A Randomized Double-Blinded, Placebo-Controlled Trial of Antibiotic Therapy in Patients With Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level
Status: Enrolling
Updated: 12/31/1969
Durham VA Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Chlamydia Trachomatis Infection Clinical Trial
Phase 2B/3 Double-blinded Placebo-controlled
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Hope Clinical Research, LLC
mi
from
Canoga Park, CA
Click here to add this to my saved trials
Chlamydia Trachomatis Infection Clinical Trial
Phase 2B/3 Double-blinded Placebo-controlled
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Cincinnati Physicians, Inc
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Chlamydia Trachomatis Infection Clinical Trial
Phase 2B/3 Double-blinded Placebo-controlled
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Global Health Research Center
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Chlamydia Trachomatis Infection Clinical Trial
Phase 2B/3 Double-blinded Placebo-controlled
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Eclipse Clinical Research
mi
from
Tucson, AZ
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital of The King's Daughters
mi
from
Norfolk, VA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Methodist Children's Hospital of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Cook Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Miller Children's and Women's Hospital Long Beach
mi
from
Long Beach, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospitals and Clinics of Minnesota - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital of New Orleans
mi
from
New Orleans, LA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital and Medical Center of Omaha
mi
from
Omaha, NE
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Arnold Palmer Hospital for Children
mi
from
Orlando, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Hospital Saint Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Madigan Army Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical City Dallas Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Jude Midwest Affiliate
mi
from
Peoria, IL
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
1 … 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 … 65